Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Abramson Cancer Center at Penn Medicine
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)
Perspective Therapeutics
National Institutes of Health Clinical Center (CC)
The University of Texas Health Science Center at San Antonio
Nanjing First Hospital, Nanjing Medical University
AC Camargo Cancer Center
University of Wuerzburg
Fudan University
First Affiliated Hospital of Zhejiang University
University of Pennsylvania
National Institutes of Health Clinical Center (CC)
Seoul National University Hospital
Cancer Research UK
Radboud University Medical Center
Fundación de investigación HM
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Universidad Nacional Autonoma de Mexico
King's College Hospital NHS Trust
Peking Union Medical College Hospital
University Hospital Olomouc
Shanghai Jiao Tong University School of Medicine